TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects October 8, 1982